Profile: ImClone Systems develops novel therapeutic products in the field of oncology. Our product erbitux® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of head & neck cancer. This product in combination with radiation therapy, is indicated for the treatment of a certain type of locally or regionally advanced head and neck cancer. It is also used for treating colorectal cancer.